His study showed that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of ...

The jump in cases can only be described as “explosive”, said Dr Kesa Tuidraki. In hospitals and clinics across Fiji, doctors ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1 ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

When it comes to HIV prevention, the U.S. Supreme Court appeared to back up the task force with its July 11 ruling in Kennedy ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Mizoram launches an intensified HIV awareness and testing drive to address high infection rates. The campaign focuses on ...

Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

In Kenya, HIV funding from the U.S. in fiscal year 2024 totaled $307.9 million, equivalent to almost a third of the country’s ...

Statistics reveal an increase in HIV infections among the youth in Kerala. In the year 2024–25, 14% of newly diagnosed cases ...

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...